GlassScriptPhysician profile
Donald Gutman
NPI 1396776738
$6,438.48
in general payments reported to CMS, 2019-2025
46 companies · $972 in 2025
The $972 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $858 · 2021: $1,020 · 2022: $986 · 2023: $1,036 · 2024: $885 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $825.76 | 2021-2025 | |
| Glaxosmithkline, LLC. | $611.21 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $564.15 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $519.96 | 2019-2025 | Jardiance, Ofev |
| Novo Nordisk INC | $514.21 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Pfizer INC. | $508.72 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $286.39 | 2019-2024 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $240.94 | 2020-2021 | |
| Exact Sciences Corporation | $231.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $166.56 | 2022-2025 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $165.13 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $154.67 | 2020-2024 | Dificid |
| Allergan, INC. | $143.34 | 2020 | |
| Astellas Pharma US INC | $136.66 | 2019-2023 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $135.04 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Gutman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.